The effects of tricyclic antidepressants on breast cancer risk
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
To test the hypothesis that tricyclic antidepressant use increases invasive female breast cancer incidence, we carried out a case–control study within the population of female beneficiaries of the Saskatchewan Prescription Drug Plan aged ⩾35 years from 1981–1995 with no history of cancer since 1970. This agency has provided full or partial coverage for outpatient prescriptions to Saskatchewan residents since 1975. We accrued 5882 histologically proven cases and 23 517 controls, randomly selected from the source population and individually matched on age and sampling time. Heavy exposure to any tricyclic antidepressants was associated with an elevated rate ratio for breast cancer 11–15 years later (2.02, 95% confidence interval: 1.34–3.04). Post hoc analyses based on the results of genotoxicity studies carried out using Drosophila melanogaster suggested that the increased risk could be attributed to the use of the six genotoxic tricyclic antidepressants, and not to the use of the four nongenotoxic tricyclic antidepressants. However, our results may have been confounded by the effects of other determinants of breast cancer associated with tricyclic antidepressant use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Risk of Breast Cancer According to Use of Antidepressants, Phenothizaines, and Anthistamines
Kelly, J. P., Rosenberg, L., Palmer, J. R., Rao, R. S., Strom, B. L., Stolley, P. D., Zauber, A. G., & Shapiro, S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010091 · Cited by 89 · cited 1×
“…epidemiologic studies found no positive associations between TCA use and the development of cancer (Danielson et al, 1982; Friedman and Ury, 1980, 1983; Kelly et al, 1999; Selby et al, 1989; Weiss et al, 1998), they were limited either by small sample size, self-reporting of use, failure to…”
Background
Cited by
Depression, quality of life and breast cancer: a review of the literature
Reich, M., Lesur, A., & Perdrizet-Chevallier, C. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9706-5 · Cited by 442
Depression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
Bibliotherapy as a Treatment for Depression in Primary Care
Naylor, E. V., Antonuccio, D. O., Litt, M., Johnson, G. E., Spogen, D. R., Williams, R., McCarthy, C., Lu, M. M., Fiore, D. C., & Higgins, D. L. (2010) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-010-9207-2 · Cited by 43
Chung, C.-M., Kuo, T.-M., Chiang, S.-L., Wang, Z.-H., Hung, C.-C., Lane, H.-Y., Liu, C.-S., & Ko, Y.-C. (2016) · Oncotarget · doi:10.18632/oncotarget.7049 · Cited by 19
Metadata
- Authors
- Sharpe, C. R., Collet, J.-P., Belzile, E., Hanley, J. A., & Boivin, J.-F.
- Venue
- British Journal of Cancer
- Published
- 2002-01
- Volume
- 86
- Issue
- 1
- Pages
- 92-97
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2030522586
- Cited by
- 93
- References
- 2
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of tricyclic antidepressants on breast cancer risk. https://app.cochat.ai/papers/10.1038/sj.bjc.6600013
- The paper
- Sharpe, C. R., Collet, J.-P., Belzile, E., Hanley, J. A., & Boivin, J.-F. (2002). The effects of tricyclic antidepressants on breast cancer risk. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6600013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.